title: The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?
authors.forename: John R
authors.initials: JR
authors.lastname: Tischner
mesh_terms: D003365:Costs and Cost Analysis; D004345:Drug Industry / Q000191:economics*; D006801:Humans; D007155:Immunologic Factors / Q000191:economics*; D007166:Immunosuppressive Agents / Q000191:economics*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000191:economics*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000191:economics*
chemical_list: D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha